Showing results (181-190 of 202) with videos related to
Sort By:
Pageof 21
The Journal of Infectious Diseases|February 28, 2002
Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patientsConstance A Benson, Steven G Deeks, Scott C Brun, et al.AIDS (London, England)|April 8, 2021
Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxisRogers Sekabira, Ian McGowan, Krista Yuhas, et al.JAMA|July 4, 2002
Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trialScott M Hammer, Florin Vaida, Kara K Bennett, et al.The Journal of Experimental Medicine|August 4, 2018
Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117Yehuda Z Cohen, Julio C C Lorenzi, Lisa Krassnig, et al.AIDS (London, England)|June 15, 2021
Frequency of post treatment control varies by antiretroviral therapy restart and viral load criteriaJesse Fajnzylber, Radwa Sharaf, John N Hutchinson, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 12, 2025
HIV Infection and Long COVID: A RECOVER Program, Electronic Health Record Based Cohort StudyKellie L Hawkins, Dima Dandachi, Zoe Verzani, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2023
Lessons From COVID-19 for Pandemic Preparedness: Proceedings From a Multistakeholder Think TankShanti Narayanasamy, Lesley H Curtis, Adrian F Hernandez, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 23, 2011
Comparative effectiveness of initial antiretroviral therapy regimens: ACTG 5095 and 5142 clinical trials relative to ART-CC cohort studyMichael J Mugavero, Margaret May, Heather J Ribaudo, et al.AIDS and Behavior|June 10, 2022
Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305)Kenneth H Mayer, Krista Yuhas, K Rivet Amico, et al.Nature|April 10, 2015
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117Marina Caskey, Florian Klein, Julio C C Lorenzi, et al.Pageof 21